Prevention of Thrombotic Events in MPN: Insights from Prof. Martin Ellis

Published on January 10, 2025

At the 4th MPN Spring Symposium, Prof. Martin Ellis and specialists discussed the prevention of thrombotic events in myeloproliferative neoplasms (MPNs), particularly in polycythemia vera (PV). They emphasized the need for a multidisciplinary approach in managing thrombotic risks, highlighting genetic monitoring (JAK2, CALR, MPL) and treatment strategies such as antithrombotic therapy, aspirin, and phlebotomy.

 

 

 

 

 

 

 

 

In the video discussion, experts explored the importance of personalized disease management and the challenges of research, particularly in pediatric patients with PV. They also discussed international collaborations to advance MPN care and personalized therapies based on genetics.

https://vimeo.com/952275827/a509368bb0?share=copy

 

Other news

A Nutritional Approach to Balancing Inflammation and Energy Production

January 10, 2025
Patients with Myeloproliferative Neoplasms (MPN) often experience symptoms like fatigue, weight fluctuations, and mental fog. But did you know that a carefully planned diet can help? Carla Not, a clinical dietitian specializing in oncology, emphasizes the importance of nutrition in managing these symptoms and improving overall well-being.        The Power of Anti-Inflammatory Diets For MPN patient

Videos from the Webinar “What is a Combo Treatment in MPN?”

January 13, 2025
On December 23rd, 2024, the Global MPN Scientific Foundation hosted a special webinar focused on combo treatments for MPNs. The session, moderated by Peter Loffelhardt, featured Prof. Haifa Al-Ali and specialists from Karyopharm, who discussed a new clinical trial combining Jakavi with other treatments.The webinar offered valuable insights into the potential benefits and challenges of combination